Major U.S. health insurers with Medicare Part D plans have started covering Novo Nordisk’s popular weight loss drug Wegovy for its heart-health benefits, according to the Wall Street Journal.
CVS, Kaiser, and Elevance are among the first Medicare plans to start covering Wegovy
